These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
298 related items for PubMed ID: 9164971
1. IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/Ipr mice. Haas C, Ryffel B, Le Hir M. J Immunol; 1997 Jun 01; 158(11):5484-91. PubMed ID: 9164971 [Abstract] [Full Text] [Related]
2. IFN-gamma limits macrophage expansion in MRL-Fas(lpr) autoimmune interstitial nephritis: a negative regulatory pathway. Schwarting A, Moore K, Wada T, Tesch G, Yoon HJ, Kelley VR. J Immunol; 1998 Apr 15; 160(8):4074-81. PubMed ID: 9558118 [Abstract] [Full Text] [Related]
3. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice. Schwarting A, Wada T, Kinoshita K, Tesch G, Kelley VR. J Immunol; 1998 Jul 01; 161(1):494-503. PubMed ID: 9647261 [Abstract] [Full Text] [Related]
5. Dichotomic effects of IFN-gamma on the development of systemic lupus erythematosus-like syndrome in MRL-lpr / lpr mice. Nicoletti F, Di Marco R, Zaccone P, Xiang M, Magro G, Grasso S, Morrone S, Santoni A, Shoenfeld Y, Garotta G, Meroni P. Eur J Immunol; 2000 Feb 15; 30(2):438-47. PubMed ID: 10671199 [Abstract] [Full Text] [Related]
6. IFN-gamma receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB x NZW)F1 mice. Haas C, Ryffel B, Le Hir M. J Immunol; 1998 Apr 15; 160(8):3713-8. PubMed ID: 9558072 [Abstract] [Full Text] [Related]
7. IgG3 production in MRL/lpr mice is responsible for development of lupus nephritis. Takahashi S, Nose M, Sasaki J, Yamamoto T, Kyogoku M. J Immunol; 1991 Jul 15; 147(2):515-9. PubMed ID: 2071894 [Abstract] [Full Text] [Related]
8. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. Takahashi S, Fossati L, Iwamoto M, Merino R, Motta R, Kobayakawa T, Izui S. J Clin Invest; 1996 Apr 01; 97(7):1597-604. PubMed ID: 8601623 [Abstract] [Full Text] [Related]
9. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival. Mannoor K, Matejuk A, Xu Y, Beardall M, Chen C. J Immunol; 2012 Apr 15; 188(8):3628-38. PubMed ID: 22407922 [Abstract] [Full Text] [Related]
10. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice. Matsumoto K, Watanabe N, Akikusa B, Kurasawa K, Matsumura R, Saito Y, Iwamoto I, Saito T. Arthritis Rheum; 2003 Feb 15; 48(2):486-94. PubMed ID: 12571859 [Abstract] [Full Text] [Related]
11. Interferon regulatory factor-1 gene deletion decreases glomerulonephritis in MRL/lpr mice. Reilly CM, Olgun S, Goodwin D, Gogal RM, Santo A, Romesburg JW, Ahmed SA, Gilkeson GS. Eur J Immunol; 2006 May 15; 36(5):1296-308. PubMed ID: 16541466 [Abstract] [Full Text] [Related]
12. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice. Yasuda T, Yoshimoto T, Tsubura A, Matsuzawa A. Cell Immunol; 2001 Jun 15; 210(2):77-86. PubMed ID: 11520074 [Abstract] [Full Text] [Related]
13. Cryoglobulinemia induced by monoclonal immunoglobulin G rheumatoid factors derived from autoimmune MRL/MpJ-lpr/lpr mice. Gyotoku Y, Abdelmoula M, Spertini F, Izui S, Lambert PH. J Immunol; 1987 Jun 01; 138(11):3785-92. PubMed ID: 3495570 [Abstract] [Full Text] [Related]
14. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice. Pérez de Lema G, Maier H, Franz TJ, Escribese M, Chilla S, Segerer S, Camarasa N, Schmid H, Banas B, Kalaydjiev S, Busch DH, Pfeffer K, Mampaso F, Schlöndorff D, Luckow B. J Am Soc Nephrol; 2005 Dec 01; 16(12):3592-601. PubMed ID: 16267157 [Abstract] [Full Text] [Related]
15. Role of the costimulatory molecule CD28 in the development of lupus in MRL/lpr mice. Tada Y, Nagasawa K, Ho A, Morito F, Koarada S, Ushiyama O, Suzuki N, Ohta A, Mak TW. J Immunol; 1999 Sep 15; 163(6):3153-9. PubMed ID: 10477582 [Abstract] [Full Text] [Related]
16. IgG1 and IgG2a production by autoimmune B cells treated in vitro with IL-4 and IFN-gamma. Klinman DM. J Immunol; 1990 Apr 01; 144(7):2529-34. PubMed ID: 2108205 [Abstract] [Full Text] [Related]
17. Interferon-beta: a therapeutic for autoimmune lupus in MRL-Faslpr mice. Schwarting A, Paul K, Tschirner S, Menke J, Hansen T, Brenner W, Kelley VR, Relle M, Galle PR. J Am Soc Nephrol; 2005 Nov 01; 16(11):3264-72. PubMed ID: 16221871 [Abstract] [Full Text] [Related]
18. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis. Steinmetz OM, Turner JE, Paust HJ, Lindner M, Peters A, Heiss K, Velden J, Hopfer H, Fehr S, Krieger T, Meyer-Schwesinger C, Meyer TN, Helmchen U, Mittrücker HW, Stahl RA, Panzer U. J Immunol; 2009 Oct 01; 183(7):4693-704. PubMed ID: 19734217 [Abstract] [Full Text] [Related]
19. Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice. Sadanaga A, Nakashima H, Akahoshi M, Masutani K, Miyake K, Igawa T, Sugiyama N, Niiro H, Harada M. Arthritis Rheum; 2007 May 01; 56(5):1618-28. PubMed ID: 17469144 [Abstract] [Full Text] [Related]
20. Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice. Sadanaga A, Nakashima H, Masutani K, Miyake K, Shimizu S, Igawa T, Sugiyama N, Niiro H, Hirakata H, Harada M. Arthritis Rheum; 2005 Dec 01; 52(12):3987-96. PubMed ID: 16320345 [Abstract] [Full Text] [Related] Page: [Next] [New Search]